Top

Published in:

Open Access 01-12-2014 | Case report

Complete remission of diffuse hepatocellular carcinoma in a young adult after GSP-TACE: a case report

Authors: Song Liu, Yuewei Zhang, Guangsheng Zhao, Ying Liu

Published in: World Journal of Surgical Oncology | Issue 1/2014

Abstract

Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver. It mostly occurs in older age groups (usually those 50 to 60 years old), and rarely in young adults. The survival rate of these young HCC patients is usually very low. The authors report a case of a 22-year old man with diffuse-type HCC who successfully achieved complete remission for 46 months after second transcatheter arterial chemoembolization using gelatin sponge particles (Eric Kang Pharmaceutical Technology Co., Ltd. Hangzhou, China) combined with pirarubicin.

Available only for authorised users

Zeng Z, Ren J, O’Neil M, Zhao J, Bridges B, Cox J, Abdulkarim B, Schmitt TM, Kumer SC, Weinman SA: Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation. BMC Cancer. 2012, 12: 584-10.1186/1471-2407-12-584.PubMedCentralCrossRefPubMed

Katyal S, Oliver JH, Peterson MS, Ferris JV, Carr BS, Baron RL: Extrahepatic metastases of hepatocellular carcinoma. Radiology. 2000, 2169 (3): 698-703.CrossRef

Anwar AM, Nosir YF, Chamsi-Pasha MA, Ajam A, Chamsipasha H: Right atrial metastasis mimicking myxoma in advanced hepatocellular carcinoma. Echocardiography. 2010, 27 (1): 80-83. 10.1111/j.1540-8175.2009.00963.x.CrossRefPubMed

Demirjian A, Peng P, Geschwind JF, Cosgrove D, Schutz J, Kamel IR, Pawlik TM: Infiltrating hepatocellular carcinoma: seeing the tree through the forest. J Gastrointest Surg. 2011, 15: 2089-2097. 10.1007/s11605-011-1614-7.PubMedCentralCrossRefPubMed

Trevisani F, Caraceni P, Bernardi M, D’Intino PE, Arienti V, Amorati P, Stefanini GF, Grazi G, Mazziotti A, Fornalè L, Gozzetti G, Gasbarrini G: Gross pathologic types of hepatocellular carcinoma in Italian patients. Relationship with demographic, environmental, and clinical factors. Cancer. 1993, 72: 1557-1563. 10.1002/1097-0142(19930901)72:5<1557::AID-CNCR2820720512>3.0.CO;2-5.CrossRefPubMed

Kanematsu M, Semelka RC, Leonardou P, Mastropasqua M, Lee JK: Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations. J Magn Reson Imaging. 2003, 18: 189-195. 10.1002/jmri.10336.CrossRefPubMed

Hernández-Castillo E, Mondragón-Sánchez R, Garduno-Lopez AL, Gómez-Gómez E, Ruiz-Molina JM, Oñate-Ocaña LF, Bernal-Maldonado R: Hepatocellular carcinoma in the youth. A comparative analysis with hepatocellular carcinoma in adulthood. Hepatogastroenterology. 2005, 52 (63): 903-907.PubMed

Aramaki M, Kawano K, Sasaki A, Ohno T, Tahara K, Kai S, Iwashita Y, Kitano S: Hepatocellular carcinoma in young adults. Hepatogastroenterology. 2005, 52 (66): 1795-1797.PubMed

Yamazaki Y, Kakizaki S, Sohara N, Sato K, Takagi H, Arai H, Abe T, Katakai K, Kojima A, Matsuzaki Y, Mori M: Hepatocellular carcinoma in young adults: the clinical characteristics, prognosis, and findings of a patient survival analysis. Dig Dis Sci. 2007, 52: 1103-1107. 10.1007/s10620-006-9578-2.CrossRefPubMed

10.

Tsai HL, Liu CS, Chin TW, Wei CF: Hepatoblastoma and hepatocellular carcinoma in children. J Chin Med Assoc. 2004, 67 (2): 83-88.PubMed

11.

Kneuertz PJ, Demirjian A, Firoozmand A, Corona-Villalobos C, Bhagat N, Herman J, Cameron A, Gurakar A, Cosgrove D, Choti MA, Geschwind JF, Kamel IR, Pawlik TM: Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes. Ann Surg Oncol. 2012, 19 (9): 2897-2907. 10.1245/s10434-012-2336-0.PubMedCentralCrossRefPubMed

12.

Yang JD, Roberts L: Epidemiology and management of hepatocellular carcinoma. Infect Dis Clin North Am. 2010, 24: 899-919. 10.1016/j.idc.2010.07.004.PubMedCentralCrossRefPubMed

13.

Llovet JM, Bru C, Bruix J: Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999, 19: 329-338. 10.1055/s-2007-1007122.CrossRefPubMed

14.

Harrison LE, Koneru B, Baramipour P, Fisher A, Barone A, Wilson D, Dela Torre A, Cho KC, Contractor D, Korogodsky M: Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg. 2003, 197: 759-764. 10.1016/S1072-7515(03)00750-6.CrossRefPubMed

15.

Njei B, Ditah I, Lim JK: Persistent racial disparities in survival among U.S. adults with hepatocellular carcinoma after liver transplantation: the paradox of all-cause and cause-specific mortality. Gastrointest Cancer Res. 2013, 6 (3): 73-74.PubMedCentralPubMed

16.

Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996, 334 (11): 693-699. 10.1056/NEJM199603143341104.CrossRefPubMed

17.

Bruix J, Sherman M: Management of hepatocellular carcinoma. Hepatology. 2005, 42: 1208-1236. 10.1002/hep.20933.CrossRefPubMed

18.

Llovet JM, Bruix J: Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003, 37: 429-442. 10.1053/jhep.2003.50047.CrossRefPubMed

19.

Cammà C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, Andreone P, Craxì A, Cottone M: Transarterial chemoembolization for unresectable hepatocellular carcinoma: metaanalysis of randomized controlled trials. Radiology. 2002, 224: 47-54. 10.1148/radiol.2241011262.CrossRefPubMed

20.

Lewis AL, Gonzalez MV, Leppard SW, Brown JE, Stratford PW, Phillips GJ, Lloyd AW: Doxorubicin eluting beads - 1: effects of drug loading on bead characteristics and drug distribution. J Mater Sci Mater Med. 2007, 18: 1691-1699. 10.1007/s10856-007-3068-8.CrossRefPubMed

21.

Varela M, Real MI, Burrel M, Forner A, Sala M, Brunet M, Ayuso C, Castells L, Montañá X, Llovet JM, Bruix J: Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol. 2007, 46: 474-481. 10.1016/j.jhep.2006.10.020.CrossRefPubMed

22.

Takayasu K, Arii S, Ikai I, Kudo M, Matsuyama Y, Kojiro M, Makuuchi M, Liver Cancer Study Group of Japan: Overall survival after transcarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis. AJR Am J Roentgenol. 2010, 194: 830-837. 10.2214/AJR.09.3308.CrossRefPubMed

23.

Zhao G-S, Liu Y, Zhang Y-W, Li C, Tang S-X, Zhou J, Liu S: Huaier granules combined with intraarterial chemoembolization for the treatment of hepatocellular carcinoma. Chin J Gen Surg. 2013, 28 (6): 440-443.

Title: Complete remission of diffuse hepatocellular carcinoma in a young adult after GSP-TACE: a case report
Authors: Song Liu
Yuewei Zhang
Guangsheng Zhao
Ying Liu
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: World Journal of Surgical Oncology / Issue 1/2014
Electronic ISSN: 1477-7819
DOI: https://doi.org/10.1186/1477-7819-12-300

At a glance: The STEP trials

Springer Medicine

Complete remission of diffuse hepatocellular carcinoma in a young adult after GSP-TACE: a case report

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

Functional imaging with diffusion-weighted MRI for lung biopsy planning: initial experience

Large cell neuroendocrine carcinoma of the ovary: a case report and a brief review of the literature

Reliable management of post-esophagectomy anastomotic fistula with endoscopic trans-fistula negative pressure drainage

Standard versus extended pneumonectomy for lung cancer: what really matters?

Autoimmune pancreatitis associated with a pancreatic pseudocyst treated by distal pancreatectomy with splenectomy: case report

Serum B7-H4 expression is a significant prognostic indicator for patients with gastric cancer